Vort John Vander, Insider at Pacira Pharmaceuticals, Inc. (PCRX), sold 500,000 shares at $27.86 ($13.9M) on 2013-03-11, disclosed to the SEC on 2013-03-13.
Open-market sale of $13.9M PCRX by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PLIN | BUY | 2009-01-15 | $49K | — | Filing → |